Synthesis and antitumor activities of rare earth substituted phosphotungstates containing 5-fluorouracil

被引:9
|
作者
Feng Changgen [1 ]
Gan Qiang [1 ]
Liu Xia [2 ]
He Hongyou [1 ]
机构
[1] Beijing Inst Technol, Sch Mechatron Engn, Beijing 100081, Peoples R China
[2] China Agr Univ, Coll Sci, Beijing 100083, Peoples R China
关键词
phosphotungstates; 5-fluorouracil; rare earth; HeLa; HepG-2; antitumor; cytotoxicity; ANTICANCER PROPERTIES; ACID; POLYOXOMETALATE;
D O I
10.1016/S1002-0721(12)60074-X
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Two novel rare earth substituted phosphotungstates containing 5-fluorouracil, K-9(C4H4FN2O2)(2)Nd(PW11O39)(2)center dot 25H(2)O (FNdPW) and K-9(C4H4FN2O2)(2)Ce(PW11O39)(2)center dot 23H(2)O (FCePW), were synthesized and characterized by elementary analysis, FT-IR spectra, X-ray powder diffraction and H-1 NMR. The thermal analysis showed that FNdPW decomposed at 210 and 493 degrees C, and FCePW decomposed at 223 and 471 degrees C, both of which had good thermal stabilities. MTT tests were performed to study the antitumor activities against HeLa cells and HepG-2 cells of FNdPW, FCePW, 5-fluorouracil, C4H4FN2O2H2PW12O40 center dot 8H(2)O and K(11)Ln(PW11O39)(2)center dot xH(2)O (Ln=Nd, Ce), and their cytotoxicities against HEK 293 cells. The results showed that FNdPW and FCePW possessed higher antitumor activities and lower cytotoxicities than those of 5- fluorouracil and C4H4FN2O2H2PW12O40 center dot 8H(2)O, of which FNdPW exhibited the highest antitumor activates against HeLa cells (EC50=3.41x10(-6) mol/L) and HepG-2 cells (EC50=6.24x10(-6) mol/L). Thus the introduction of rare earth elements and 5-fluorouracil could significantly enhance antitumor effect polyoxometalates.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 50 条
  • [41] Syntheses and antitumor activities of polymers containing 2-acrylamido-2-methyl-1-propanesulfonic acid or 5-fluorouracil
    Lee, SM
    Ju, SS
    Chung, HY
    Ha, CS
    Cho, WJ
    POLYMER BULLETIN, 2001, 46 (04) : 241 - 248
  • [42] Syntheses and antitumor activities of polymers containing 2-acrylamido-2-methyl-1-propanesulfonic acid or 5-fluorouracil
    Sun Mi Lee
    Seong Suk Ju
    Hae Young Chung
    Chang Sik Ha
    Won Jei Cho
    Polymer Bulletin, 2001, 46 : 241 - 248
  • [43] Synthesis and characterization of polyesteramides containing 5-fluorouracil in the main chain
    Chang, Jun
    Li, Cheng Wu
    Li, Gang
    MATERIALS AND DESIGN, PTS 1-3, 2011, 284-286 : 1728 - 1731
  • [44] 5-Fluorouracil derivatives - XXIII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils having aromatic ring
    Ozaki, S
    Kong, XZ
    Watanabe, Y
    Hoshiko, T
    Ogasawara, T
    Ueno, T
    Furukawa, U
    Iigo, M
    Hoshi, A
    CHINESE JOURNAL OF CHEMISTRY, 1998, 16 (02) : 171 - 177
  • [45] Synthesis of 1-arylated derivatives of 5-fluorouracil as potential antitumor drugs
    You, JZ
    Chen, SY
    Wang, YG
    Chen, YZ
    JOURNAL OF CHEMICAL RESEARCH-S, 2000, (10): : 466 - 467
  • [46] Synthesis, structure and antitumor activity of dibutyltin oxide complex with 5-fluorouracil derivatives
    Zuo, DS
    Jiang, T
    Guan, HS
    Qi, X
    Wang, KQ
    Shi, Z
    CHINESE JOURNAL OF CHEMISTRY, 2001, 19 (11) : 1141 - 1145
  • [47] SYNTHESIS AND STRUCTURE-ANTITUMOR ACTIVITY RELATIONSHIP OF SULFONYL 5-FLUOROURACIL DERIVATIVES
    Yan, Xiaowei
    Hou, Yong
    Chen, Fan
    Zhao, Kejian
    Hu, Maolin
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2010, 185 (01) : 158 - 164
  • [48] CONVENIENT SYNTHESIS OF 5-FLUOROURACIL
    BARTON, DHR
    TOH, HT
    HESSE, RH
    PECHET, MM
    JOURNAL OF ORGANIC CHEMISTRY, 1972, 37 (02): : 329 - &
  • [49] Synthesis of 1-arylsulfonyl-3-N-(β-D-acetylglycopyranos-1-yl)-5-fluorouracil and antitumor activities
    Sun, CJ
    Zhang, JM
    Wang, SJ
    Zhou, FY
    Qi, YX
    Lu, M
    SYNTHETIC COMMUNICATIONS, 2001, 31 (01) : 71 - 75
  • [50] NOVEL DERIVATIVES OF 5-FLUOROURIDINE AND 5-FLUOROURACIL HAVING POTENT ANTITUMOR AND LOWER IMMUNOSUPPRESSIVE ACTIVITIES
    MORI, H
    SAKAMOTO, O
    KITAICHI, K
    KODA, A
    KITA, J
    JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 58 (03): : 269 - 282